Corgi FundsLeveraged EquityXBIX · Cboe BZX

Corgi U.S. Biotech 2x Daily ETF (XBIX)

Compare categoryCompare Leveraged & Inverse ETFs Compare with others

Price: $31.82; —12 Nov 2026
Assets: $340,000; Total net assets
Expense ratio: 0.45%; Category 0.00%
Yield: —; Trailing distributions

1Y return: —; Category -16.9%
3Y CAGR: —; Category 25.2%
5Y CAGR: —; Category 1.4%

$31.82—12 Nov 2026

Fund

Assets: $340,000
Expense: 0.45%
Categ. exp: 0.00%
Yield: —

ReturnFundCateg.

1Y—-16.9%

3Y—25.2%

5Y—1.4%

Launch23.3%—

Loading NAV history…

Corgi U.S. Biotech 2x Daily ETF

Calendar-year returns

Fund only: no comparison series covers this fund's history.

Risk statistics

Five years of daily closes. Risk-free rate 4% a year.

Standard deviation: —
Maximum drawdown: —
Sharpe ratio: —
Sortino ratio: —
Beta: —
Alpha: —
R²: —
Information ratio: —
Upside capture: —
Downside capture: —
Tracking error: —

Trailing returns compared with benchmark
Period	1M	3M	6M	YTD	1Y	3YCAGR	5YCAGR	10YCAGR	LaunchCAGR
ETF	+3.5%	-12.6%	—	—	—	—	—	—	+23.3%
Leveraged Equity average	-25.0%	-32.7%	-30.0%	-13.3%	-16.9%	25.2%	1.4%	8.6%	-24.6%
Difference	+28.5%	+20.1%	—	—	—	—	—	—	+47.8%

Holdings

This ETF publishes no holdings breakdown.

ETF details

Issuer: Corgi Funds
Category: Equity · Leveraged Equity
Ticker: XBIX
Exchange: Cboe BZX
Inception: 2 Jun 2026 (0.4 years)
Structure: Exchange Traded Fund
Expense ratio: 0.45% (category 0.00%)
Holdings turnover: 0%
Distribution yield: —
Beta, 3 years: 0.00
Total net assets: $340,000

Prices and returns as of 12 Nov 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.

Other leveraged equity ETFs

Other ETFs in the Leveraged Equity category.

Compare Leveraged & Inverse ETFs